BeStock  
Markets › Compare › MNPR vs STTK

MNPR vs STTK

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MNPR · Monopar Therapeutics$83.78 ▲ 5.29%
STTK · Shattuck Labs$5.66 ▼ 3.50%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

31119208297385Oct 9, '25Apr 9, '26Oct 7, '26
  • MNPR -17.0%
  • STTK +157.0%

Head to head

MetricMNPRSTTK
Price$83.78$5.66
Change today▲ 5.29%▼ 3.50%
Market cap$562.35M$567.55M
Return, 3 months-19.8%-19.6%
Return, year to date+28.3%+54.9%
Return, 1 year-15.0%+136.6%
P/E (TTM)-38.1-12.9
P/B4.32.7
P/E percentile vs own 5y5th4th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-116.6%-21.6%
Gross margin––
Operating margin–-5,578.6%
Net margin–-5,256.8%
Return on equity-19.5%-39.2%
Analyst target vs. price+54.3%+180.5%
Analyst buy share86%100%
RSI (14)3435
30-day volatility45.0%56.1%
Max drawdown, 1 year-50.9%-50.5%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • STTK is the largest of the group by market value.
  • STTK has returned the most over the past year.
  • MNPR carries the lowest trailing P/E.
  • MNPR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top